Singulair (montelukast) for asthma

March 1998

Merck is introducing Singulair (montelukast) for asthma.

It's a new leukotriene antagonist...similar to Accolate (zafirlukast).

Some leukotrienes are potent bronchoconstrictors. In fact they used to be called "slow-reacting substance of anaphylaxis."

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Hear a lot more about homocysteine
Venastat to relieve leg swelling due to varicose veins
Singulair (montelukast) for asthma
Serevent is approved for treating chronic obstructive pulmonary disease (COPD)
Obesity & Weight Loss New obesity drug, Meridia
Cardiology New combination antihypertensive called Teczem
Cardiology Whether patients can still take erythromycin before dental procedures to prevent bacterial endocarditis
Neurology & Pain New oral migraine drug, Amerge
Neurology & Pain Tasmar (tolcapone) for Parkinson's
Women's Health New strength of Prempro
Women's Health Topical testosterone for libido
Gastroenterology PrevPac, a new kit for H. pylori
Diabetes Boxed warning about which patients shouldn't take metformin (Glucophage)
Diabetes Another new drug for type 2 diabetes, called Prandin (repaglinide)
STIs New STD treatment guidelines
Poison Prevention National Poison Prevention Week is this month